Infusion Therapy Devices Market Report 2025

This Infusion Therapy Devices market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The infusion therapy devices market size has grown rapidly in recent years. It will grow from $12.1 billion in 2024 to $13.43 billion in 2025 at a compound annual growth rate (CAGR) of 11%. The growth in the historical period can be attributed to factors such as increasing hospital admissions, advancements in healthcare infrastructure, government initiatives, medical tourism, and favorable reimbursement policies.

The infusion therapy devices market size is expected to see rapid growth in the next few years. It will grow to $20.11 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth during the forecast period is driven by the impact of personalized medicine, enhanced pandemic preparedness and response, the rise of wearable infusion devices, the shift towards infusion therapy, and the ongoing digitalization of healthcare. Key trends expected in the forecast period include 5G connectivity, quantum computing, integration of the Internet of Things (IoT), wearable health technology, and the use of voice assistants and natural language processing.

The rising incidence of chronic diseases is anticipated to drive the growth of the infusion therapy devices market. Chronic diseases, which are long-term health conditions lasting over a year and requiring continuous medical attention or limiting daily activities, are becoming more common due to factors such as poor lifestyle choices, sedentary habits, unhealthy diets, environmental influences, and risk factors such as obesity, smoking, and stress. Infusion therapy devices help manage these conditions by delivering medications and fluids directly into the bloodstream in a precise and controlled manner, ensuring effective treatment for conditions such as diabetes, autoimmune disorders, and cancer. This approach enhances patient outcomes, increases convenience, and reduces the need for frequent hospital visits. For example, a report from the National Center for Biotechnology Information (NCBI) in January 2023 projected that by 2050, the number of individuals over the age of 50 with at least one chronic illness will increase by 99.5%, from 71.522 million in 2020 to 142.66 million. As a result, the growing prevalence of chronic diseases is contributing to the market expansion of infusion therapy devices.

Companies in the infusion therapy devices market are focusing on innovations such as pressure-enabled drug delivery (PEDD) technology to improve treatments for liver and pancreatic tumors. PEDD is a technology that uses pressure to enhance the infusion of therapeutic agents into tissues or organs, particularly in cases where traditional methods may not be as effective. In November 2024, TriSalus Life Sciences, a US-based medical technology company, introduced the TriNav LV Infusion System and TriGuide Guiding Catheters, expanding its PEDD portfolio to improve therapeutic delivery and potentially enhance treatment outcomes. The TriNav LV Infusion System offers features such as accommodating larger blood vessels (3.5 to 5 mm), which broadens the patient population eligible for PEDD technology. This launch increases device compatibility from 1.5 mm to 5 mm vessels, providing more treatment options for interventional radiologists. The TriGuide Guiding Catheters have a larger inner diameter, a lubricious lining, and a reverse curve design, improving femoral access and procedural efficiency. Early users report a 97% satisfaction rate, highlighting the system's effectiveness and ease of use in oncology treatments.

In July 2024, ICU Medical Inc., a US-based medical technology company, acquired Smiths Medical Inc. for an undisclosed sum. This acquisition aims to strengthen ICU Medical’s infusion therapy product line and expand its portfolio into new clinical care markets, offering a more comprehensive range of infusion systems and related products. Smiths Medical Inc. is a US-based manufacturer of medical devices, including infusion therapy devices.

Major players in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, Acelity L.P Inc., LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., AccuVein Inc.

North America was the largest region in the infusion therapy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in infusion therapy devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the infusion therapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Infusion therapy devices are medical tools used to administer fluids, medications, nutrients, or blood products directly into a patient's bloodstream. These devices are highly versatile, enhancing patient care by ensuring the accurate and controlled delivery of fluids, medications, and nutrition.

The main types of infusion therapy devices include intravenous (IV) sets, cannulas, and needleless connectors. Infusion pumps are specialized devices that deliver controlled amounts of fluids, medications, or nutrients into a patient's body. These pumps come in various mobility options, such as portable and stationary pumps, and are used for different applications including oncology, diabetes, pain management, and more. They serve a wide range of end users, including hospitals, clinics, ambulatory surgical centers, home care settings, and others.

The infusion therapy devices market research report is one of a series of new reports that provides infusion therapy devices market statistics, including infusion therapy devices industry global market size, regional shares, competitors with infusion therapy devices market share, detailed infusion therapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the infusion therapy devices industry. This infusion therapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infusion therapy devices market consists of sales of products including pumps, catheters, sets, ports, and accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.